ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Molecular landscape for risk prediction and personalized therapeutics of castration-resistant prostate cancer: at a glance

Jian, Jingang; Wang, Xin'an; Zhang, Jun; Zhou, Chenchao; Hou, Xiaorui; Huang, Yuhua; Hou, Jianquan*; Lin, Yuxin*; Wei, Xuedong*苏州大学; 同济大学
Frontiers in Endocrinology2024-6-3DOI: 10.3389/fendo.2024.1360430
3阅读
引用收藏
分享

摘要

Prostate cancer (PCa) is commonly occurred with high incidence in men worldwide, and many patients will be eventually suffered from the dilemma of castration-resistance with the time of disease progression. Castration-resistant PCa (CRPC) is an advanced subtype of PCa with heterogeneous carcinogenesis, resulting in poor prognosis and difficulties in therapy. Currently, disorders in androgen receptor (AR)-related signaling are widely acknowledged as the leading cause of CRPC development, and some non-AR-based strategies are also proposed for CRPC clinical analyses. The initiation of CRPC is a consequence of abnormal interaction and regulation among molecules and pathways at multi-biological levels. In this study, CRPC-associated genes, RNAs, proteins, and metabolites were manually collected and integrated by a comprehensive literature review, and they were functionally classified and compared based on the role during CRPC evolution, i.e., drivers, suppressors, and biomarkers, etc. Finally, translational perspectives for data-driven and artificial intelligence-powered CRPC systems biology analysis were discussed to highlight the significance of novel molecule-based approaches for CRPC precision medicine and holistic healthcare.

学科与关键词

关键词
castration-resistant prostate cancermolecular signaturescarcinogenic mechanismspersonalized medicinemedical systems biology
相关
加载中…
  • From molecular mechanisms of prostate cancer to translational applications: based on multi-omics fusion analysis and intelligent medicine
    Ren, Shumin; Li, Jiakun; Dorado, Julian; Sierra, Alejandro; Gonzalez-Diaz, Humbert; Duardo, Aliuska; Shen, Bairong*HEALTH INFORMATION SCIENCE AND SYSTEMS, 2023, 12(1): 6.被引 2
  • Regression of Castration-Resistant Prostate Cancer by a Novel Compound HG122
    Cong, Xiaonan; He, Yundong; Wu, Haigang; Wang, Dingxiang; Liu, Yongrui; Shao, Ting; Liu, Mingyao; Yi, Zhengfang; Zheng, Jianghua; Peng, Shihong*; Ding, Tao*Frontiers in Oncology, 2021, 11: 650919.被引 4
  • Integrative Analysis of Androgen Receptor Interactors Aberrations and Associated Prognostic Significance in Prostate Cancer
    Wang, Zhu; Zhang, Ying; Deng, Qiong; Zhang, Jianwen; Wang, Xisheng*; Liang, Hui*Urology Journal, 2023, 20(5): 318-328.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Endocrinology
发表日期
2024-06-03
卷期
第 15 卷
页码
1360430
DOI
10.3389/fendo.2024.1360430
成果收录
SCIE
资助标注
National Natural Science Foundation of China [32200533]; General Program of Jiangsu Health Commission [H2019040]; Suzhou Science and Technology Plan Project [SLJ2022008]

作者

  • J

    Jian, Jingang (第一作者)

    soochow univ

  • W

    Wang, Xin'an

    tongji univ

查看全部 9 位作者收起作者
  • Z

    Zhang, Jun

    soochow univ

  • Z

    Zhou, Chenchao

    soochow univ

  • H

    Hou, Xiaorui

    soochow univ

  • H

    Huang, Yuhua

    soochow univ

  • H

    Hou, Jianquan (通讯)

    soochow univ

  • L

    Lin, Yuxin (通讯)

    soochow univ

  • W

    Wei, Xuedong (通讯)

    soochow univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417